×
About 4,948 results

ALLMedicine Hyperkalemia Center

Research & Reviews  1,993 results

Prevalence and economic burden of hyperkalemia in the United States Medicare population.
https://doi.org/10.1080/03007995.2020.1775072
Current Medical Research and Opinion; Mu F, Betts KA et. al.

May 26th, 2020 - Objective: To estimate the prevalence and economic burden of hyperkalemia in the United States (US) Medicare population.Methods: Patients were selected from a 5% random sample of Medicare beneficiaries (01/01/2010-12/31/2014) to estimate the preva...

Report: central diabetes insipidus and schwannoma in a male with X-linked congenital ad...
https://doi.org/10.1186/s12902-020-00553-0
BMC Endocrine Disorders; Seo BK, Jeong SA et. al.

May 26th, 2020 - DAX1 mutations are related to the X-linked form of adrenal hypoplasia congenita (AHC) in infancy and to hypogonadotropic hypogonadism (HH) in puberty. We report a male patient affected by X-linked AHC who presented with central diabetes insipidus ...

Uremia Medication
https://emedicine.medscape.com/article/245296-medication

May 26th, 2020 - Medication Summary Usually, medications employed in the management of uremia are indicated for associated metabolic and electrolyte abnormalities, such as anemia, hyperkalemia, hypocalcemia, hyperparathyroidism, and iron deficiency. Agents used in...

Hyperkalemia in heart failure: Foe or friend?
https://doi.org/10.1002/clc.23392
Clinical Cardiology REFERENCES; Rakisheva A, Marketou M et. al.

May 22nd, 2020 - Hyperkalemia is a frequent and sometimes life-threatening condition that may be associated with arrhythmia and cardiac dysfunction in patients with heart failure (HF). High potassium levels in HF represent both a direct risk for cardiovascular com...

Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyp...
https://doi.org/10.1111/hdi.12845
Hemodialysis International. International Symposium on Home Hemodialysis REFERENCES; Pirklbauer M

May 19th, 2020 - Significant deviations of serum potassium and sodium levels are frequently observed in hospitalized patients and are both associated with increased all-cause and cardiovascular mortality. The presence of acute or chronic renal failure facilitates ...

see more →

Drugs  165 results see all →

Clinicaltrials.gov  2,439 results

Prevalence and economic burden of hyperkalemia in the United States Medicare population.
https://doi.org/10.1080/03007995.2020.1775072
Current Medical Research and Opinion; Mu F, Betts KA et. al.

May 26th, 2020 - Objective: To estimate the prevalence and economic burden of hyperkalemia in the United States (US) Medicare population.Methods: Patients were selected from a 5% random sample of Medicare beneficiaries (01/01/2010-12/31/2014) to estimate the preva...

Report: central diabetes insipidus and schwannoma in a male with X-linked congenital ad...
https://doi.org/10.1186/s12902-020-00553-0
BMC Endocrine Disorders; Seo BK, Jeong SA et. al.

May 26th, 2020 - DAX1 mutations are related to the X-linked form of adrenal hypoplasia congenita (AHC) in infancy and to hypogonadotropic hypogonadism (HH) in puberty. We report a male patient affected by X-linked AHC who presented with central diabetes insipidus ...

Uremia Medication
https://emedicine.medscape.com/article/245296-medication

May 26th, 2020 - Medication Summary Usually, medications employed in the management of uremia are indicated for associated metabolic and electrolyte abnormalities, such as anemia, hyperkalemia, hypocalcemia, hyperparathyroidism, and iron deficiency. Agents used in...

Hyperkalemia in heart failure: Foe or friend?
https://doi.org/10.1002/clc.23392
Clinical Cardiology REFERENCES; Rakisheva A, Marketou M et. al.

May 22nd, 2020 - Hyperkalemia is a frequent and sometimes life-threatening condition that may be associated with arrhythmia and cardiac dysfunction in patients with heart failure (HF). High potassium levels in HF represent both a direct risk for cardiovascular com...

Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyp...
https://doi.org/10.1111/hdi.12845
Hemodialysis International. International Symposium on Home Hemodialysis REFERENCES; Pirklbauer M

May 19th, 2020 - Significant deviations of serum potassium and sodium levels are frequently observed in hospitalized patients and are both associated with increased all-cause and cardiovascular mortality. The presence of acute or chronic renal failure facilitates ...

see more →

News  351 results

Is Hyperkalemia Always Bad in Patients With Heart Failure?
https://www.medscape.com/viewarticle/926082

Mar 11th, 2020 - This transcript has been edited for clarity. Hello. This is Ileana Piña. I'm a professor of medicine at Wayne State University, and this is my blog. We're going to talk about potassium. We have talked about potassium before. If you look at the lit...

Low RAAS inhibitor dosing linked to MACE risk
https://www.mdedge.com/cardiology/article/214456/heart-failure/low-raas-inhibitor-dosing-linked-mace-risk?channel=39313
Bianca Nogrady

Dec 17th, 2019 - Suboptimal dosing of renin-angiotensin-aldosterone system (RAAS) inhibitors to reduce the risk of hyperkalemia could increase the risk of major adverse cardiac events (MACE) and all-cause mortality in patients with chronic kidney disease (CKD) or.

SZC passes extension test for hyperkalemia
https://www.mdedge.com/cardiology/article/214327/hypertension/szc-passes-extension-test-hyperkalemia?channel=224
Jim Kling

Dec 14th, 2019 - Treatment with sodium zirconium cyclosilicate (SZC) led to lasting improvement of hyperkalemia, according to results from an 11-month open-label extension study of the HARMONIZE randomized clinical trial. SZC selectively binds potassium ions in th.

Hyperkalemia-related treatment changes linked to death in acute HF
https://www.mdedge.com/cardiology/article/212834/heart-failure/hyperkalemia-related-treatment-changes-linked-death-acute-hf?channel=39313
Catherine Hackett

Nov 21st, 2019 - The hyperkalemia that commonly occurs in patients hospitalized for acute heart failure does not affect outcomes, but it can lead to treatment changes that can in turn raise the risk of mortality. That’s according to an analysis of data from 1,589.

Potassium Disturbances Common in Patients Hospitalized With Heart Failure
https://www.medscape.com/viewarticle/920272

Oct 22nd, 2019 - NEW YORK (Reuters Health) - Inpatient therapy for heart failure may induce iatrogenic hypokalemia or hyperkalemia, which in themselves appear not to be harmful - but related changes in medication might be, according to an international group of re...

see more →